Incorporation of Calcimimetics into End-Stage Kidney Disease Bundle: Changes in Etelcalcetide Utilization and Parathyroid Hormone Control following End of Transitional Drug Add-On Payment Adjustment Designation
Clin J Am Soc Nephrol. 2024 Oct 8.
doi: 10.2215/CJN.0000000583.
Online ahead of print.